Zoë MacDonald

Associate

旧金山 + 1.415.875.5772

联系：

Share

Zoë MacDonald advises public and private companies on mergers and acquisitions and strategic transactions in domestic and cross-border matters. She has experience across a range of industries, including technology, artificial intelligence, financial technology, life sciences, and health care.

Most recently, Zoë assisted with Bora Pharmaceuticals' $122.5 million acquisition of the GMP manufacturing operations of MacroGenics (Nasdaq: MGNX).

Outside of her transactional work, Zoë is committed to an active pro bono practice through the Firm's Border Project, where she provides on-the-ground legal support to asylum clients at detention facilities in Laredo, Texas.

Zoë is the author of "Defending Children’s Data Privacy: Strategies for the 21st Century," 76 UC Law SF L.J. 589 (2025).

经验

  • Bora Pharmaceuticals acquires MacroGenics, Inc.'s GMP manufacturing operationsJones Day represented Bora Pharmaceuticals Co., Ltd. in its acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc. (Nasdaq: MGNX) for $122.5 million cash.
  • Wells Fargo provides loan to national real estate development companyJones Day represented Wells Fargo Bank, National Association, in connection with a $331.9 million loan provided to a national real estate development company, secured by ten industrial properties located in Arizona, California, Nevada, and Texas.
  • Wells Fargo provides $245 million term loan secured by 44 industrial properties across five statesJones Day represented Wells Fargo Bank, National Association, as administrative agent, in connection with a $245 million term loan secured by a portfolio of industrial properties located in five states.
    •

    February 2026 Commentary

    Registration Under California Digital Financial Assets Law Begins March 9, Law Takes Effect July 1

    January 2026 Alert

    United Kingdom Unveils FSMA-Based Regulatory Regime for Cryptoassets

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice